Di Marco A, Casazza A M, Gambetta R, Supino R, Zunino F
Cancer Res. 1976 Jun;36(6):1962-6.
The effects of 4'-epi-daunorubicin, 4'-epi-adriamycin, and the corresponding beta anomers on the in vitro activity of Escherichia coli DNA polymerase I and RNA polymerase were determined and compared with the effects of the parent compounds. The observed effects parallel the cytotoxic activities, assayed by inhibition of mouse embryo fibroblast proliferation, and the inhibitory activities on DNA synthesis in cultured cells. The data indicate that the inverted configuration at position 1 of the amino sugar results in a markedly reduced biological activity. This conclusion is also substantiated by the data obtained with the beta anomer of adriamycin. A preliminary investigation on the binding properties of these derivatives suggests that the inverted configuration at C-1' produces a significant decrease in the binding to DNA. In contrast, epimerization at position 4' did not produce any significant change in activity. The relationship between biological and biochemical activity and DNA binding properties of the tested compounds are discussed with particularly reference to antitumor activity.
测定了4'-表柔红霉素、4'-表阿霉素及其相应的β-端基异构体对大肠杆菌DNA聚合酶I和RNA聚合酶体外活性的影响,并与母体化合物的影响进行了比较。观察到的这些影响与通过抑制小鼠胚胎成纤维细胞增殖测定的细胞毒性活性以及对培养细胞中DNA合成的抑制活性相似。数据表明氨基糖1位的构型翻转导致生物活性显著降低。阿霉素β-端基异构体获得的数据也证实了这一结论。对这些衍生物结合特性的初步研究表明,C-1'位的构型翻转会导致与DNA的结合显著减少。相比之下,4'位的差向异构化并未使活性产生任何显著变化。结合抗肿瘤活性,特别讨论了受试化合物的生物活性、生化活性与DNA结合特性之间的关系。